Epidemiological features and prognostic factors of cutaneous head and neck melanoma: A population-based study

Archives of Otolaryngology - Head and Neck Surgery

Volumn 133, Issue 5, 2007, Pages 442-447

  Golger, Alexander ^a   Young, Diana S ^a   Ghazarian, Danny ^b   Neligan, Peter C ^a,c  

^a UNIVERSITY OF TORONTO   (Canada)

^b PRINCESS MARGARET HOSPITAL   (Canada)

^c TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANADA; CANCER EPIDEMIOLOGY; CANCER MORTALITY; CANCER RISK; CONFIDENCE INTERVAL; DATA ANALYSIS; DEMOGRAPHY; FEMALE; HAZARD ASSESSMENT; HEAD AND NECK CANCER; HUMAN; MAJOR CLINICAL STUDY; MALE; MELANOMA; POPULATION RESEARCH; PROPORTIONAL HAZARDS MODEL; SEX RATIO;

AGED; CATCHMENT AREA (HEALTH); COHORT STUDIES; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; HUTCHINSON'S MELANOTIC FRECKLE; INCIDENCE; MALE; MELANOMA; NEOPLASM INVASIVENESS; ONTARIO; POPULATION SURVEILLANCE; PREVALENCE; PROGNOSIS; SKIN NEOPLASMS; SURVIVAL RATE;

EID: 34249090728     PISSN: 08864470     EISSN: 08864470     Source Type: Journal    
DOI: 10.1001/archotol.133.5.442     Document Type: Article

References (15)

1. Thörn M, Adami HO, Ringborg U, Bergstrom R, Krusemo U. The association between anatomic site and survival in malignant melanoma: an analysis of 12,353 cases from the Swedish Cancer Registry. Eur J Cancer Clin Oncol. 1989;25: 483-491.
2. World Health Organization. International Classification of Diseases, Ninth Revision (ICD-9). Geneva, Switzerland: World Health Organization; 1977.
3. Tsao H, Atkins MB, Sober AJ. Management of cutaneous melanoma. N Engl J Med. 2004;351:998-1012.
4. Canadian Cancer Society, National Cancer Institute of Canada, Health Canada, and Statistics Canada. Canadian cancer statistics 2004. http://www.cancer.ca /vgn/images/portal/cit_86751114/14/33/ 195986411niw_stats2004_en.pdf. Accessed January 13, 2005.
5. Ringborg U, Afzelius L, Lagerlof B, et al. Cutaneous malignant melanoma of the head and neck: analysis of treatment results and prognostic factors in 581 patients: a report from the Swedish Melanoma Study Group. Cancer. 1993;71:751-758.
6. Cox NH, Aitchison TC, Sirel JM, MacKie RM. Comparison between lentigo maligna melanoma and other histogenetic types of malignant melanoma of the head and neck. Br J Cancer. 1996;73:940-944.
7. Langford FP, Fisher SR, Molter DW, Seigler HF. Lentigo maligna melanoma of the head and neck. Laryngoscope. 1993;103:520-524.
8. Gillgren P, Mansson-Brahme E, Frisell J, Johansson H, Larsson O, Ringborg U. Epidemiological characteristics of cutaneous malignant melanoma of the head and neck: a population-based study. Acta Oncol. 1999;38:1069-1074.
9. Fisher SR. Cutaneous malignant melanoma of the head and neck. Laryngoscope. 1989;99:822-836.
10. Hersey P, Sillar RW, Howe CG, et al. Factors related to the presentation of patients with thick primary melanomas. Med J Aust. 1991;154:583-587.
11. Chang AE, Karnell LH, Menck HR; American College of Surgeons Commission on Cancer and American Cancer Society. The National Cancer Data Base report on cutaneous and noncutaneous melanoma: a summary of 84,836 cases from the past decade. Cancer. 1998;83:1664-1678.
12. Esmaeli B, Wang B, Deavers M, et al. Prognostic factors for survival in malignant melanoma of the eyelid skin. Ophthal Plast Reconstr Surg. 2000;16:250-257.
13. Wanebo HJ, Cooper PH, Young DV, Harpole DH, Kaiser DL. Prognostic factors in head and neck melanoma. Cancer. 1988;62:831-837.
14. Urist MM, Balch CM, Soong S-J, et al. Head and neck melanoma in 534 clinical stage I patients: a prognostic factors analysis and results of surgical treatment. Ann Surg. 1984;200:769-775.
15. Gillgren P, Mansson-Brahme E, Frisell J, Johansson H, Larsson O, Ringborg U. A prospective population-based study of cutaneous malignant melanoma of the head and neck. Laryngoscope. 2000;110:1498-1504.